Rui Han

State Key Laboratory Of Chemical Engineering And Low Carbon Technology, Membrane Science And Engineering R&D Lab, 130 Meilong Road
Meilong, 200237, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Positively Charged NF Membranes with Co-Enhanced Donnan and Size-Sieving Effects Fabricated Toward Efficient Li+/Mg2+ Separation.

Positively Charged NF Membranes with Co-Enhanced Donnan and Size-Sieving Effects Fabricated Toward Efficient Li+/Mg2+ Separation.

Journal: Membranes
Published: July 07, 2026

Chitooligosaccharide/Polydopamine Co-Deposition Modifying Substrates for High-Performance Forward Osmosis Membranes with Enhanced Antibacterial and Antifouling Properties.

Chitooligosaccharide/Polydopamine Co-Deposition Modifying Substrates for High-Performance Forward Osmosis Membranes with Enhanced Antibacterial and Antifouling Properties.

Journal: Membranes
Published: April 26, 2026

Blautia-PTGS1 co-occurrence in prolactinomas: potential implications for tumor microenvironment and invasiveness.

Blautia-PTGS1 co-occurrence in prolactinomas: potential implications for tumor microenvironment and invasiveness.

Journal: Journal of the Endocrine Society
Published: November 10, 2025

Biosensor-Based Comparison of Stress Responses in Qingtian Paddy Field Carp (Cyprinus carpio var. qingtianensis) and Xingguo Red Carp (Cyprinus carpio var. singuonensis) Under Acute Shallow Water Conditions.

Biosensor-Based Comparison of Stress Responses in Qingtian Paddy Field Carp (Cyprinus carpio var. qingtianensis) and Xingguo Red Carp (Cyprinus carpio var. singuonensis) Under Acute Shallow Water Conditions.

Journal: Biology
Published: August 27, 2025

Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort study.

Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort study.

Journal: Molecular therapy. Oncology
Published: May 10, 2025

Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy.

Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy.

Journal: Vaccines
Published: April 05, 2025

Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer.

Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer.

Journal: Experimental hematology & oncology
Published: March 16, 2025

HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization.

HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization.

Journal: Vaccines
Published: December 18, 2024

Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy.

Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy.

Journal: International journal of nanomedicine
Published: January 24, 2024

Whether membranes developed for organic solvent nanofiltration (OSN) tend to be hydrophilic or hydrophobic? ── a review.

Whether membranes developed for organic solvent nanofiltration (OSN) tend to be hydrophilic or hydrophobic? ── a review.

Journal: Heliyon
Published: September 05, 2023

Proteogenomic characterization of skull-base chordoma.

Proteogenomic characterization of skull-base chordoma.

Journal: Nature communications
Published: August 09, 2023

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.

Journal: Cell research
Published: March 12, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026